From: Estimation of healthcare‐related charges in women with BRCA mutations and breast cancer
Health care charges ($US) | Overall n=816 | BRCAm n=134 | BRCAwt n=682 | BRCAm vs. BRCAwt | |||
---|---|---|---|---|---|---|---|
Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | Mean (SD) | Median (IQR) | p-value | |
Facilities/ Technical | 29,090 (26,802)33.8%a | 24,027 (34,043) | 35,130 (28,878) 40.5% | 33,037 (42,145) | 27,903 (26,234) 32.5% | 22,458 (32,529) | 0.01 |
Physician/ Professional | 15,615 (13,126), 18.2% | 12,441 (17,669) | 16,207 (12,198), 18.7% | 15,624 (18,967) | 15,498 (13,306) 18.1% | 11,908 (16,906) | 0.25 |
Pharmacy | 41,277 (69,308) 48.0% | 9,313 (58,716) | 35,352 (51,919) 40.8% | 11,379 (54,399) | 42,442 (72,209) 49.4% | 8,930 (59,659) | 0.65 |
Total Anticancer Treatment | 24,616 (56,779) | 2,018 (15,804) | 16,821 (38,088) | 2,756 (14,673) | 26,148 (59,671) | 1,824 (15,995) | 0.72 |
Other Medication(s) | 16,661 (24,471) | 2,911 (27,834) | 18,531 (24,484) | 6,035 (30,729) | 16,294 (24,470) | 2,609 (26,434) | 0.19 |
Clinical Trial | 56 (347) | 0 (0) | 89 (621) | 0 (0) | 49 (262) | 0 (0) | 0.93 |
Chemotherapy | 7,171 (14,088) | 1,372 (6,575) | 8,439 (14,791) | 2,344 (9,463) | 6,922 (13,944) | 1,180 (6,124) | 0.13 |
Hormonal Therapy | 890 (5,521) | 0 (0) | 769 (4,334) | 0 (0) | 914 (5,728) | 0 (0) | 0.53 |
Biologic Medicine | 16,499 (50,091) | 0 (0) | 7,524 (30,898) | 0 (0) | 18,262 (52,891) | 0 (0) | 0.02 |
Chemotherapy Administration | 0 (5) | 0 (0) | 1 (7) | 0 (0) | 0 (5) | 0 (0) | NA |
Total Charges | 85,982 (94,087) | 55,230 (94,787) | 86,689 (75,937) | 65,414 (95,894) | 85,843 (97,304) | 54,635 (94,085) | 0.19 |